Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New ultrasound and blood tests may replace liver biopsies for obese patients

NCT ID NCT07172997

First seen Oct 31, 2025 · Last updated Jun 19, 2026 · Updated 30 times

Summary

This study looks at 163 bariatric surgery patients to see if non-invasive tools like ultrasound and blood tests can accurately diagnose a common liver disease called MASLD. Researchers will also search for biomarkers that predict whether type 2 diabetes goes into remission after weight-loss surgery. Participants are assessed before surgery and at 6 and 12 months after.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Alhakeem Radiology Center

    Manama, Manama, 2901, Bahrain

  • King Hamad University Hospital

    Al Muharraq, Muharraq, Bahrain

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Bariatric Surgery

What this could lead to

If successful, this could replace invasive liver biopsies with simple ultrasound and blood tests for diagnosing liver disease in obese patients.

What could go wrong

This is an observational study, not a treatment trial. The scoring system needs further validation before it can be used in practice.

Conditions

The condition(s) this trial relates to.

metabolic dysfunction-associated steatotic liver disease Obesity obesity disorder type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.